Federated Hermes’s Microbot Medical MBOT Stock Holding History

Federated Hermes’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-10	Closed	-$1K	–	2165
2017 Q1	$1K	Buy	+10	New	+$878	﹤0.01%	2081

Other funds holding MBOT

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Federated Hermes's MBOT Position: Q2 2017 in Review

Federated Hermes sold out of Microbot Medical (MBOT) in Q2 2017, closing a stake of 10 shares — an estimated $1K sold.

Federated Hermes first reported a position in MBOT in Q1 2017 and held it in 1 quarter. The position peaked at $1K in Q1 2017. 24 funds tracked by Wall St. Rank hold MBOT as of Q2 2017.

Federated Hermes reported no remaining Microbot Medical position as of Q2 2017 after selling out during the quarter.
Federated Hermes sold 10 Microbot Medical shares in Q2 2017, an estimated $1K.
Federated Hermes first reported a position in Microbot Medical in Q1 2017 and held it in 1 quarter.
Federated Hermes's Microbot Medical position peaked at $1K in Q1 2017.
24 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2017.

Based on Federated Hermes's 13F filing for Q2 2017, filed 4 Aug 2017.